Alexander Kolevzon, MD Email Alexander Kolevzon
-
- Positions
- PROFESSOR | Psychiatry
- PROFESSOR | Pediatrics
-
- Specialties
- Psychiatry
- Child and Adolescent Psychiatry
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Queens
- Mount Sinai Brooklyn
-
- Phone
- Physician Office 212-659-8752 212-659-8752
Dr. Alex Kolevzon is a child and adolescent psychiatrist and Professor of Psychiatry and Pediatrics at the Icahn School of Medicine at Mount Sinai. He serves as the Director of Child and Adolescent Psychiatry for the Mount Sinai Health System and the Clinical Director of the Seaver Autism Center for Research and Treatment at Mount Sinai. His research interests pertain to understanding the neurobiology of autism and related neurodevelopmental disorders, biomarker discovery, and developing novel therapeutics. Most recently, his group has focused on studying specific genetic forms of autism, including Phelan-McDermid syndrome, FOXP1 syndrome, and ADNP syndrome, in order to explore targets for pharmacological intervention. Dr. Kolevzon leads the Experimental Therapeutics Program at the Seaver Autism Center which conducts studies that range from small pilot trials to multi-centered pivotal FDA studies. He also leads a national rare disease clinical research network dedicated to clinical trial readiness and studying the natural history of Phelan-McDermid syndrome. He is a frequently invited speaker regionally, nationally, and internationally and is also extremely committed to medical student and residency education as an active teacher, mentor, and clinical supervisor.
Financial & Billing Information
Please direct any detailed billing or financial inquires to the Mount Sinai Psychiatry billing customer service number at 212-659-8752.
Clinical Focus
- Anxiety
- Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
- Autism
- Child Psychiatry Consultation
- Cognitive-Behavioral Therapy (CBT)
- Obsessive-Compulsive Disorder
- Psychotherapy
Research Topics
Autism, Behavioral Health, Personalized Medicine, Pharmacology, Psychiatry
Education
MD, Sackler School of Medicine
Residency, Clinical Psychiatry
Icahn School of Medicine
Fellowship, Child Psychiatry
Icahn School of Medicine
Language
English
2020
RARE Champion of Hope Award
Global Genes
2012
Teacher of the Year Award in Child and Adolescent Psychiatry
Division of Child and Adolescent Psychiatry, Mount Sinai
2011
Outstanding Mentor Award
American Academy of Child and Adolescent Psychiatry
2007
Excellence in Teaching Award
2006
Junior Faculty Development Award
Association of Academic Psychiatry
2005
AACAP Pilot Research Award
2003
Richard L. Scharf Memorial Award for Teaching Excellence
2003
Outstanding Child and Adolescent Psychiatry Resident Award
American Academy of Child and Adolescent Psychiatry
2002
Outstanding Resident Award
National Institute of Mental Health
2001
Alpha Omega Alpha (AOA)
2001
Teacher of the Year Award in General Psychiatry
Department of Psychiatry, Mount Sinai
Dr. Kolevzon's research interests include the biological causes and effective treatment of autism and related pervasive developmental disorders. He is also committed to medical student and residency training and education and interested in developing innovative educational programs.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Kolevzon during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Acadia
- Ellis and Winters, LLP
- Gerson Lehrman Group
- Ovid Therapeutics
- Quinn Attorney at Law
- Sema4
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Therapy Lab
Scientific Advisory Board:
- David Lynch Foundation
- Klingenstein Third Generation Foundation
- Therapy Lab
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.